Treatment choice in metaplastic breast cancer: A report of 5 cases

Metaplastic breast carcinoma (MBC) is a general term defining a heterogeneous group that includes biphasic lesions, with both malignant epithelial and mesenchymal tissue components. Although its clinical findings are similar to those present in invasive ductal carcinoma, it rarely presents with the...

Full description

Saved in:
Bibliographic Details
Published inNorthern clinics of Istanbul Vol. 5; no. 4; pp. 365 - 369
Main Authors Acar, Turan, Acar, Nihan, Sezgin, Gulten, Gokova, Melek Bekler, Kucukzeybek, Betul Bolat, Haciyanli, Mehmet
Format Journal Article
LanguageEnglish
Published Turkey Kare Publishing 01.01.2018
KARE Publishing
Subjects
breast
cancer; lymph; metaplastic; node; sentinel
Case Report
Breast
node
sentinel
lymph
cancer
metaplastic
Online AccessGet full text

Cover

More Information
Summary:Metaplastic breast carcinoma (MBC) is a general term defining a heterogeneous group that includes biphasic lesions, with both malignant epithelial and mesenchymal tissue components. Although its clinical findings are similar to those present in invasive ductal carcinoma, it rarely presents with the findings of inflammatory breast cancer. It is generally seen in the fifth decade. MBC spreads via lymph and blood circulation. Most common distant metastasis areas include lungs and the bone. Although the treatment generally relies on the same principles applied in invasive ductal carcinoma, a more aggressive treatment should be employed in at-risk groups due to higher rates of local recurrence. In this study, we aimed to discuss clinicopathological features and treatment approach in 5 women with MBC.
ISSN:2536-4553
2148-4902
DOI:10.14744/nci.2018.09124